Iktos
Data as of .
Company facts
-
Founded
2016
-
Headquarters
France (Paris)
Latest funding round
- Round
- Series A
- Date
- Mar 2023
- Amount
- EUR 15.5M (approx. $16.4M)
- Lead investor
- M Ventures and Debiopharm Innovation Fund (co-leads)
Drug discovery partners
2 pharma, 1 other. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
Pierre Fabre Pharma
AI oncology drug discovery partnership,
Terms not disclosed
-
Servier Pharma
AI drug discovery partnership,
Up to EUR 1B total potential (approx. $1.17B), upfront not disclosed
-
Cube Biotech Biotech
AI drug discovery collaboration,
Terms not disclosed
Big tech ties
Not counted as pharma partners.
-
AWS
Featured in AWS Pioneers Project,
Recent news
-
Featured in an AWS Pioneers Project video on its robotics and AI chemistry
-
Pierre Fabre partners with Iktos on AI-driven oncology drug discovery
-
Iktos and Servier launch an AI drug discovery partnership reported at up to EUR 1B
-
AI drug discovery collaboration with Cube Biotech
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.